Association of paediatric inflammatory bowel disease with other immune-mediated diseases

Archives of Disease in Childhood

Volumn 96, Issue 11, 2011, Pages 1042-1046

  Kappelman, Michael D ^a   Galanko, Joseph A ^a   Porter, Carol Q ^b   Sandler, Robert S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ALLERGIC RHINITIS; ARTICLE; ASTHMA; AUTOIMMUNE DISEASE; CHILD; COMORBIDITY; CONTROLLED STUDY; CROHN DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; ECZEMA; ENTERITIS; FEMALE; HUMAN; HYPOTHYROIDISM; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; ULCERATIVE COLITIS;

ADOLESCENT; ARTHRITIS, RHEUMATOID; AUTOIMMUNE DISEASES; CHILD; COLITIS, ULCERATIVE; COMORBIDITY; CROHN DISEASE; DIABETES MELLITUS, TYPE 1; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; HYPOTHYROIDISM; INFLAMMATORY BOWEL DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MASSACHUSETTS; YOUNG ADULT;

EID: 80054742849     PISSN: 00039888     EISSN: 14682044     Source Type: Journal    
DOI: 10.1136/archdischild-2011-300633     Document Type: Article

References (21)

1. Loftus EV, Jr. Clinical epidemiology of inflammatory bowel disease: incidence, prevalence, and environmental influences. Gastroenterology 2004;126:1504-17.
2. Loftus EV, Jr. The burden of inflammatory bowel disease in the United States: a moving target? Clin Gastroenterol Hepatol 2007;5:1383-4.
3. Kappelman MD, Rifas-Shiman SL, Kleinman K, et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. Clin Gastroenterol Hepatol 2007;5:1424-9. (Pubitemid 350181588)
4. Kappelman MD, Rifas-Shiman SL, Porter CQ, et al. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology 2008;135:1907-13.
5. Witte J, Shivananda S, Lennard-Jones JE, et al. Disease outcome in inflammatory bowel disease: mortality, morbidity and therapeutic management of a 796-person inception cohort in the European Collaborative Study on Inflammatory Bowel Disease (EC-IBD). Scand J Gastroenterol 2000;35:1272-7. (Pubitemid 32051641)
6. Cohen RD. The quality of life in patients with Crohn's disease. Aliment Pharmacol Ther 2002;16:1603-9.
7. McLeod RS, Churchill DN, Lock AM, et al. Quality of life of patients with ulcerative colitis preoperatively and postoperatively. Gastroenterology 1991;101:1307-13.
8. Bernstein CN, Wajda A, Blanchard JF. The clustering of other chronic inflammatory diseases in inflammatory bowel disease: a population-based study. Gastroenterology 2005;129:827-36. (Pubitemid 41242675)
9. Cohen R, Robinson D, Jr, Paramore C, et al. Autoimmune disease concomitance among inflammatory bowel disease patients in the United States, 2001-2002. Inflamm Bowel Dis 2008;14:738-43. (Pubitemid 351898056)
10. Weng X, Liu L, Barcellos LF, et al. Clustering of inflammatory bowel disease with immune mediated diseases among members of a northern California-managed care organization. Am J Gastroenterol 2007;102:1429-35. (Pubitemid 46976291)
11. Gupta G, Gelfand JM, Lewis JD. Increased risk for demyelinating diseases in patients with inflammatory bowel disease. Gastroenterology 2005;129:819-26. (Pubitemid 41242674)
12. Bardella MT, Elli L, De Matteis S, et al. Autoimmune disorders in patients affected by celiac sprue and inflammatory bowel disease. Ann Med 2009;41:139-43.
13. de Ridder L, Weersma RK, Dijkstra G, et al. Genetic susceptibility has a more important role in pediatric-onset Crohn's disease than in adult-onset Crohn's disease. Inflamm Bowel Dis 2007;13:1083-92. (Pubitemid 47402591)
14. Loftus EV, Jr. Inflammatory bowel disease extending its reach. Gastroenterology 2005;129:1117-20.
15. Stempel DA, Mauskopf J, McLaughlin T, et al. Comparison of asthma costs in patients starting fluticasone propionate compared to patients starting montelukast. Respir Med 2001;95:227-34. (Pubitemid 32624461)
16. Gart JJ, Zweifel JR. On the bias of various estimators of the logit and its variance with application to quantal bioassay. Biometrika 1967;54:181-7.
17. Satsangi J, Silverberg MS, Vermeire S, et al. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut 2006;55:749-53. (Pubitemid 43764536)
18. Feeney MA, Murphy F, Clegg AJ, et al. A case-control study of childhood environmental risk factors for the development of inflammatory bowel disease. Eur J Gastroenterol Hepatol 2002;14:529-34. (Pubitemid 34518185)
19. Van Limbergen J, Russell RK, Nimmo ER, et al. Filaggrin loss-of-function variants are associated with atopic comorbidity in pediatric inflammatory bowel disease. Inflamm Bowel Dis 2009;15:1492-8.
20. Herrinton LJ, Liu L, Lafata JE, et al. Estimation of the period prevalence of inflammatory bowel disease among nine health plans using computerized diagnoses and outpatient pharmacy dispensings. Inflamm Bowel Dis 2007;13:451-61. (Pubitemid 46668251)
21. Bernstein CN, Blanchard JF. The epidemiology of Crohn's disease. Gastroenterology 1999;116:1503-4.